GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Pozycja w akcjach
#3679
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Cena akcji
$27.06
Kapitalizacja rynkowa
$4.58B
Zmiana (1 dzień)
-1.73%
Zmiana (1 rok)
-13.66%
Kraj
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategoria
Healthcare
Liczba akcji w obrocie dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Liczba akcji w obrocie na dzień June 2026: 169.41M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji GlaxoSmithKline Pharmaceuticals Limited, aktualna liczba akcji w obrocie to 169.41M. Na koniec March 2024 firma posiadała 169.41M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO) od 2004 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2026 (TTM) | 169.41M | 0.00% |
| 2025 | 169.41M | 0.00% |
| 2024 | 169.41M | -0.50% |
| 2023 | 170.26M | -4.88% |
| 2022 | 178.98M | 5.65% |
| 2021 | 169.41M | 0.00% |
| 2020 | 169.41M | 0.00% |
| 2019 | 169.41M | 0.00% |
| 2018 | 169.41M | 0.00% |
| 2017 | 169.41M | 0.00% |
| 2016 | 169.41M | 0.00% |
| 2015 | 169.41M | 0.00% |
| 2013 | 169.41M | 0.00% |
| 2012 | 169.41M | 0.00% |
| 2011 | 169.41M | 0.00% |
| 2010 | 169.41M | 0.00% |
| 2009 | 169.41M | 0.00% |
| 2008 | 169.41M | 0.00% |
| 2007 | 169.41M | 0.00% |
| 2006 | 169.41M | -1.29% |
| 2005 | 171.62M | -1.73% |
| 2004 | 174.65M | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 892.40M | 426.78% |
US
|
|
| 2.45B | 1,344.78% |
US
|
|
| 1.77B | 945.41% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | 369.88% |
CH
|
